UnitedHealth Group Incorporated
UNH
Positions held
Your positionsUNH isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- UnitedHealth Group is well-positioned in the healthcare plans industry, benefiting from a growing demand for health services and an aging population.
- In Q2 2026, revenue was $112.0 billion, showing a 0% increase compared to the previous quarter.
- The company has a strong earnings growth rate of 61.5%, indicating robust profitability potential.
- The healthcare plans industry faces regulatory challenges that could impact profitability and operational flexibility.
- Gross margin decreased to 20.8% in Q2 2026 from 22.7% in the prior quarter, indicating potential cost pressures.
- The company's operating margin was only 7.1% in Q2 2026, down from 8.0% in Q1 2026, reflecting declining operational efficiency.
Fundamentals
| Market cap | $332.96B | Enterprise value | $382.32B | Trailing P/E | 23.86 | Forward P/E | 16.41 |
| PEG | 1.02 | Price / book | 3.41 | Beta | 0.62 | Dividend yield | 2.50% |
| Revenue growth | 0.4% | Earnings growth | 61.5% | Gross margin | 19.7% | Operating margin | 7.1% |
| Profit margin | 3.1% | ROE | 14.2% | ROA | 4.9% | Debt / equity | 0.69 |
| Current ratio | 0.78 | Free cash flow | $24.27B | Analyst recommendation | buy | Mean target | $481.72 |
| 52w high | $461.62 | 52w low | $255.97 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $112.0B | $111.7B | $113.2B | $113.2B | $111.6B |
| Op margin | 7.1% | 8.0% | 0.3% | 3.8% | 4.6% |
| Net income | $5.5B | $6.3B | $10.0M | $2.3B | $3.4B |
| Gross margin | 20.8% | 22.7% | 16.3% | 18.2% | 17.9% |
| Gross profit | $23.3B | $25.4B | $18.5B | $20.6B | $20.0B |
| Operating income | $8.0B | $9.0B | $380M | $4.3B | $5.2B |
- Revenue +0% vs prior quarter ($112.0B vs $111.7B).
- Gross margin 20.8% (was 22.7% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $447.6B | $400.3B | $371.6B | $324.2B | — |
| Op margin | 4.2% | 8.1% | 8.7% | 8.8% | — |
| Net income | $12.1B | $14.4B | $22.4B | $20.1B | — |
| Gross margin | 18.5% | 22.3% | 24.5% | 24.6% | — |
| Gross profit | $82.9B | $89.4B | $91.0B | $79.6B | — |
| Operating income | $19.0B | $32.3B | $32.4B | $28.4B | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Humana Leads Managed Care Peers in 2027 Medicare Advantage Star Ratings, Deutsche Bank Says
2026-10-09 · CVS Stock Dips After Drop in Medicare Advantage Plan Ratings
2026-10-09 · UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?
2026-10-09 · Does UnitedHealth (UNH) Present a Case for Patience in a Margin-Repair Story?
2026-10-09 · Seniors Face an 18% Drop in Highly Rated Medicare Advantage Plans — But Quality Might Not Be the Cause
2026-10-09 · Humana Stock Jumps After Insurer Gets High Medicare Ratings
2026-10-09 · Humana Stock Surges After Key Medicare Advantage Plan Gets Higher Rating
2026-10-09 · Is Clover Health Stock Too Dependent On One Group Of Members?
2026-10-09 · Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady
2026-10-09 · TD Cowen Cuts Price Target on UnitedHealth Group to $402 From $430
Price (daily)
Full chart · RSI · MACD · patternsOn Trade and Ticker
